Aneuploidy in Lewy body diseases

Neurobiology of Aging

Volumn 36, Issue 3, 2015, Pages 1253-1260

  Yang, Yue ^a,b   Shepherd, Claire ^a,b   Halliday, Glenda ^a,b  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Aneuploidy; Lewy bodies; Lewy body diseases; Neurofibrillary tangles; Neuronal degeneration; amyloid plaques

Indexed keywords

DNA; ALPHA SYNUCLEIN;

AGED; ANEUPLOIDY; ANTERIOR CINGULATE; ARTICLE; BRAIN WEIGHT; CELL DENSITY; CELL LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA CONTENT; FEMALE; FLOW CYTOMETRY; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NERVE CELL; NERVE CELL DEGENERATION; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN LOCALIZATION; SUBSTANTIA NIGRA; BRAIN CORTEX; GENETICS; LEWY BODY; METABOLISM; NERVE DEGENERATION; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; ANEUPLOIDY; CEREBRAL CORTEX; DNA; FEMALE; HIPPOCAMPUS; HUMANS; LEWY BODIES; LEWY BODY DISEASE; MALE; NERVE DEGENERATION; NEUROFIBRILLARY TANGLES;

EID: 84923618691     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.12.016     Document Type: Article

References (53)

1. Andorfer C., Acker C.M., Kress Y., Hof P.R., Duff K., Davies P. Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms. J.Neurosci. 2005, 25:5446-5454.
2. Arendt T., Bruckner M.K., Mosch B., Losche A. Selective cell death of hyperploid neurons in Alzheimer's disease. Am. J. Pathol. 2010, 177:15-20.
3. Bernstein H.G., Johnson M., Perry R.H., LeBeau F.E., Dobrowolny H., Bogerts B., Perry E.K. Partial loss of parvalbumin-containing hippocampal interneurons in dementia with Lewy bodies. Neuropathology 2011, 31:1-10.
4. Bhaskar K., Miller M., Chludzinski A., Herrup K., Zagorski M., Lamb B.T. The PI3K-Akt-mTOR pathway regulates Abeta oligomer induced neuronal cell cycle events. Mol. Neurodegener. 2009, 4:14.
5. Braak H., Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Aging 1995, 16:271-278. discussion 8-84.
6. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 2003, 24:197-211.
7. Braak H., Sastre M., Del Tredici K. Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease. Acta Neuropathol. 2007, 114:231-241.
8. Brion J.P., Couck A.M. Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5. Am. J. Pathol. 1995, 147:1465-1476.
9. Buee L., Troquier L., Burnouf S., Belarbi K., Van der Jeugd A., Ahmed T., Fernandez-Gomez F., Caillierez R., Grosjean M.E., Begard S., Barbot B., Demeyer D., Obriot H., Brion I., Buee-Scherrer V., Maurage C.A., Balschun D., D'Hooge R., Hamdane M., Blum D., Sergeant N. From tau phosphorylation to tau aggregation: what about neuronal death?. Biochem. Soc. Trans. 2010, 38:967-972.
10. Bushman D.M., Chun J. The genomically mosaic brain: aneuploidy and more in neural diversity and disease. Semin. Cell Dev. Biol. 2013, 24:357-369.
11. Coleman A.W., Maguire M.J., Coleman J.R. Mithramycin- and 4'-6-diamidino-2-phenylindole (DAPI)-DNA staining for fluorescence microspectrophotometric measurement of DNA in nuclei, plastids, and virus particles. J.Histochem. Cytochem. 1981, 29:959-968.
12. de Calignon A., Fox L.M., Pitstick R., Carlson G.A., Bacskai B.J., Spires-Jones T.L., Hyman B.T. Caspase activation precedes and leads to tangles. Nature 2010, 464:1201-1204.
13. Dickson D.W., Braak H., Duda J.E., Duyckaerts C., Gasser T., Halliday G.M., Hardy J., Leverenz J.B., Del Tredici K., Wszolek Z.K., Litvan I. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol. 2009, 8:1150-1157.
14. Fearnley J.M., Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991, 114(Pt 5):2283-2301.
15. Granic A., Padmanabhan J., Norden M., Potter H. Alzheimer Abeta peptide induces chromosome mis-segregation and aneuploidy, including trisomy 21: requirement for tau and APP. Mol. Biol. Cell 2010, 21:511-520.
16. Granic A., Potter H. Mitotic spindle defects and chromosome mis-segregation induced by LDL/cholesterol-implications for Niemann-Pick C1, Alzheimer's disease, and atherosclerosis. PLoS One 2013, 8:e60718.
17. Greffard S., Verny M., Bonnet A.M., Beinis J.Y., Gallinari C., Meaume S., Piette F., Hauw J.J., Duyckaerts C. Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra. Arch. Neurol. 2006, 63:584-588.
18. Hallgren J., Pietrzak M., Rempala G., Nelson P.T., Hetman M. Neurodegeneration-associated instability of ribosomal DNA. Biochim. Biophys. Acta 2014, 1842:860-868.
19. Halliday G., Hely M., Reid W., Morris J. The progression of pathology in longitudinally followed patients with Parkinson's disease. Acta Neuropathol. 2008, 115:409-415.
20. Halliday G., Lees A., Stern M. Milestones in Parkinson's disease-clinical and pathologic features. Mov. Disord. 2011, 26:1015-1021.
21. Halliday G.M., McCann H. The progression of pathology in Parkinson's disease. Ann. N. Y. Acad. Sci. 2010, 1184:188-195.
22. Harding A.J., Lakay B., Halliday G.M. Selective hippocampal neuron loss in dementia with Lewy bodies. Ann. Neurol. 2002, 51:125-128.
23. Henchcliffe C., Burke R.E. Increased expression of cyclin-dependent kinase 5 in induced apoptotic neuron death in rat substantia nigra. Neurosci. Lett. 1997, 230:41-44.
24. Herculano-Houzel S., Lent R. Isotropic fractionator: a simple, rapid method for the quantification of total cell and neuron numbers in the brain. J.Neurosci. 2005, 25:2518-2521.
25. Herrup K. The contributions of unscheduled neuronal cell cycle events to the death of neurons in Alzheimer's disease. Front. Biosci. (Elite Ed) 2012, 4:2101-2109.
26. Hoglinger G.U., Breunig J.J., Depboylu C., Rouaux C., Michel P.P., Alvarez-Fischer D., Boutillier A.L., Degregori J., Oertel W.H., Rakic P., Hirsch E.C., Hunot S. The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:3585-3590.
27. Iourov I.Y., Vorsanova S.G., Yurov Y.B. Single cell genomics of the brain: focus on neuronal diversity and neuropsychiatric diseases. Curr. Genomics 2012, 13:477-488.
28. Irwin D.J., Lee V.M., Trojanowski J.Q. Parkinson's disease dementia: convergence of alpha-synuclein, tau and amyloid-beta pathologies. Nat. Rev. Neurosci. 2013, 14:626-636.
29. Joelving F.C., Billeskov R., Christensen J.R., West M., Pakkenberg B. Hippocampal neuron and glial cell numbers in Parkinson's disease-a stereological study. Hippocampus 2006, 16:826-833.
30. Kalia L.V., Kalia S.K., McLean P.J., Lozano A.M., Lang A.E. Alpha-synuclein oligomers and clinical implications for Parkinson disease. Ann. Neurol. 2013, 73:155-169.
31. Kapuscinski J. DAPI: a DNA-specific fluorescent probe. Biotech. Histochem. 1995, 70:220-233.
32. Kril J.J., Halliday G.M., Svoboda M.D., Cartwright H. The cerebral cortex is damaged in chronic alcoholics. Neuroscience 1997, 79:983-998.
33. Kril J.J., Hodges J., Halliday G. Relationship between hippocampal volume and CA1 neuron loss in brains of humans with and without Alzheimer's disease. Neurosci. Lett. 2004, 361:9-12.
34. Kuchibhotla K.V., Wegmann S., Kopeikina K.J., Hawkes J., Rudinskiy N., Andermann M.L., Spires-Jones T.L., Bacskai B.J., Hyman B.T. Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits invivo. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:510-514.
35. Lee S.S., Kim Y.M., Junn E., Lee G., Park K.H., Tanaka M., Ronchetti R.D., Quezado M.M., Mouradian M.M. Cell cycle aberrations by alpha-synuclein over-expression and cyclin B immunoreactivity in Lewy bodies. Neurobiol. Aging 2003, 24:687-696.
36. McKeith I.G., Dickson D.W., Lowe J., Emre M., O'Brien J.T., Feldman H., Cummings J., Duda J.E., Lippa C., Perry E.K., Aarsland D., Arai H., Ballard C.G., Boeve B., Burn D.J., Costa D., Del Ser T., Dubois B., Galasko D., Gauthier S., Goetz C.G., Gomez-Tortosa E., Halliday G., Hansen L.A., Hardy J., Iwatsubo T., Kalaria R.N., Kaufer D., Kenny R.A., Korczyn A., Kosaka K., Lee V.M., Lees A., Litvan I., Londos E., Lopez O.L., Minoshima S., Mizuno Y., Molina J.A., Mukaetova-Ladinska E.B., Pasquier F., Perry R.H., Schulz J.B., Trojanowski J.Q., Yamada M. Consortium on DLB. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005, 65:1863-1872.
37. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991, 41:479-486.
38. Murphy K.E., Gysbers A.M., Abbott S.K., Tayebi N., Kim W.S., Sidransky E., Cooper A., Garner B., Halliday G.M. Reduced glucocerebrosidase is associated with increased alpha-synuclein in sporadic Parkinson's disease. Brain 2014, 137:834-848.
39. Nakamura S., Kawamoto Y., Nakano S., Akiguchi I., Kimura J. p35nck5a and cyclin-dependent kinase 5 colocalize in Lewy bodies of brains with Parkinson's disease. Acta Neuropathol. 1997, 94:153-157.
40. Parkkinen L., O'Sullivan S.S., Collins C., Petrie A., Holton J.L., Revesz T., Lees A.J. Disentangling the relationship between Lewy bodies and nigral neuronal loss in Parkinson's disease. J.Parkinsons Dis. 2011, 1:277-286.
41. Sekiyama K., Sugama S., Fujita M., Sekigawa A., Takamatsu Y., Waragai M., Takenouchi T., Hashimoto M. Neuroinflammation in Parkinson's disease and related disorders: a lesson from genetically manipulated mouse models of alpha-synucleinopathies. Parkinsons Dis. 2012, 2012:271732.
42. Shepherd C.E., Thiel E., McCann H., Harding A.J., Halliday G.M. Cortical inflammation in Alzheimer disease but not dementia with Lewy bodies. Arch. Neurol. 2000, 57:817-822.
43. Spires T.L., Orne J.D., SantaCruz K., Pitstick R., Carlson G.A., Ashe K.H., Hyman B.T. Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy. Am. J. Pathol. 2006, 168:1598-1607.
44. Spires-Jones T.L., de Calignon A., Matsui T., Zehr C., Pitstick R., Wu H.Y., Osetek J.D., Jones P.B., Bacskai B.J., Feany M.B., Carlson G.A., Ashe K.H., Lewis J., Hyman B.T. Invivo imaging reveals dissociation between caspase activation and acute neuronal death in tangle-bearing neurons. J.Neurosci. 2008, 28:862-867.
45. Spires-Jones T.L., Kopeikina K.J., Koffie R.M., de Calignon A., Hyman B.T. Are tangles as toxic as they look?. J.Mol. Neurosci. 2011, 45:438-444.
46. van de Nes J.A., Nafe R., Schlote W. Non-tau based neuronal degeneration in Alzheimer's disease-an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex. Brain Res. 2008, 1213:152-165.
47. Vekrellis K., Xilouri M., Emmanouilidou E., Rideout H.J., Stefanis L. Pathological roles of alpha-synuclein in neurological disorders. Lancet Neurol. 2011, 10:1015-1025.
48. Vickers J.C., Tan A., Dickson T.C. Direct determination of the proportion of intra- and extra-cellular neocortical neurofibrillary tangles in Alzheimer's disease. Brain Res. 2003, 971:135-137.
49. Westra J.W., Rivera R.R., Bushman D.M., Yung Y.C., Peterson S.E., Barral S., Chun J. Neuronal DNA content variation (DCV) with regional and individual differences in the human brain. J.Comp. Neurol. 2010, 518:3981-4000.
50. Xu X., Lei Y., Luo J., Wang J., Zhang S., Yang X.J., Sun M., Nuwaysir E., Fan G., Zhao J., Lei L., Zhong Z. Prevention of beta-amyloid induced toxicity in human iPS cell-derived neurons by inhibition of cyclin-dependent kinases and associated cell cycle events. Stem Cell Res. 2013, 10:213-227.
51. Yasuda T., Nakata Y., Mochizuki H. alpha-Synuclein and neuronal cell death. Mol. Neurobiol. 2013, 47:466-483.
52. Young N.A., Flaherty D.K., Airey D.C., Varlan P., Aworunse F., Kaas J.H., Collins C.E. Use of flow cytometry for high-throughput cell population estimates in brain tissue. Front. Neuroanat. 2012, 6:27.
53. Yurov Y.B., Vorsanova S.G., Liehr T., Kolotii A.D., Iourov I.Y. Xchromosome aneuploidy in the Alzheimer's disease brain. Mol. Cytogenet. 2014, 7:20.